Bioniche launches injection for varicose veins in the U.

Bioniche launches injection for varicose veins in the U here .S Bioniche Lifestyle Sciences has announced that its Pharma Division has launched Sotradecol Injection in the usa. Sotradecol is authorized by the U.S. Meals and Medication Administration for the treating little, uncomplicated varicose veins of the low extremities. It is found in sclerotherapy . Around 1.7 million sufferers undergo sclerotherapy each full season in the U.S. Related StoriesUSA Vein Treatment centers to open new middle in Marietta, GANew PlasmaDerm remedy facilitates faster curing of wounds We are thrilled to end up being launching Sotradecol, stated Albert Beraldo, President & CEO of Bioniche Pharma Group Small.

propecia wikipedia suomi

Related StoriesMD Anderson research reveals why chemotherapy medicines not effective for most pancreatic cancer patientsCrucial modification in single DNA bottom predisposes children to intense form of cancerMeat-rich diet plan may increase kidney cancers risk We are very happy to announce that people are initiating the Stage 1 tolerability scientific trial. We are assured that the trial will proceed and successfully quickly. We are executing on all our milestones diligently, non-clinical and clinical actions, in 2011, commented Dr. Isaac Cohen, Chief and Chairman Executive Officer of Bionovo, Inc. This Phase 1 medical trial is screening two dosages of Menerba that are greater than the currently proven efficacious dosage evaluated in our Stage 2 trial, which demonstrated efficacy equal to lately approved low dosage menopausal hormone therapy .